Condition

Systemic Sclerosis Associated Interstitial Lung Disease clinical trials and research

• 2Clinical trials
• 18Countries

All recruiting trials (2)

• Evaluating Genakumab for Lung Disease Related to Connective Tissue Disorders

  This study is testing whether an injection called Genakumab can help people with lung disease caused by connective tissue disorders like rheumatoid arthritis and systemic sclerosis feel better.

  Recruiting at 3 sites Phase 2 Changchun GeneScience Pharmaceutical Co., Ltd. · Beijing, Beijing Municipality and 3 other locations · NCT06189495

• Evaluating belimumab for treating lung disease in systemic sclerosis

  This study is testing if belimumab can help improve lung function and overall quality of life for adults with lung disease caused by systemic sclerosis.

  Recruiting at 114 sites Phase 2/3 GlaxoSmithKline · Phoenix, Arizona and 133 other locations · NCT05878717

Related topics

Quick answers

How many Systemic Sclerosis Associated Interstitial Lung Disease clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in China (2 trials), Argentina (1 trial), Australia (1 trial), Belgium (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →